vs
Side-by-side financial comparison of iRhythm Holdings, Inc. (IRTC) and TOOTSIE ROLL INDUSTRIES INC (TR). Click either name above to swap in a different company.
iRhythm Holdings, Inc. is the larger business by last-quarter revenue ($208.9M vs $196.3M, roughly 1.1× TOOTSIE ROLL INDUSTRIES INC). TOOTSIE ROLL INDUSTRIES INC runs the higher net margin — 14.7% vs 2.7%, a 12.0% gap on every dollar of revenue. On growth, iRhythm Holdings, Inc. posted the faster year-over-year revenue change (27.1% vs 1.5%). TOOTSIE ROLL INDUSTRIES INC produced more free cash flow last quarter ($61.0M vs $14.5M). Over the past eight quarters, iRhythm Holdings, Inc.'s revenue compounded faster (25.8% CAGR vs 13.2%).
iRhythm Holdings is a digital healthcare company focused on cardiac care, developing and commercializing wearable ambulatory heart monitoring devices paired with AI-powered analytical tools. It primarily serves healthcare providers and patients across the United States, helping to detect undiagnosed arrhythmias such as atrial fibrillation through convenient long-term heart rhythm tracking that delivers actionable clinical insights.
Tootsie Roll Industries is an American manufacturer of confectionery based in Chicago, Illinois. Its best-known products include the namesake Tootsie Rolls and Tootsie Pops. Tootsie Roll Industries currently markets its brands internationally in Canada, Mexico, and over 75 other countries.
IRTC vs TR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $208.9M | $196.3M |
| Net Profit | $5.6M | $28.8M |
| Gross Margin | 70.9% | 35.7% |
| Operating Margin | 1.1% | 17.0% |
| Net Margin | 2.7% | 14.7% |
| Revenue YoY | 27.1% | 1.5% |
| Net Profit YoY | 518.5% | 27.9% |
| EPS (diluted) | $0.18 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $208.9M | $196.3M | ||
| Q3 25 | $192.9M | $232.7M | ||
| Q2 25 | $186.7M | $155.1M | ||
| Q1 25 | $158.7M | $148.5M | ||
| Q4 24 | $164.3M | $193.4M | ||
| Q3 24 | $147.5M | $225.9M | ||
| Q2 24 | $148.0M | $150.7M | ||
| Q1 24 | $131.9M | $153.2M |
| Q4 25 | $5.6M | $28.8M | ||
| Q3 25 | $-5.2M | $35.7M | ||
| Q2 25 | $-14.2M | $17.5M | ||
| Q1 25 | $-30.7M | $18.1M | ||
| Q4 24 | $-1.3M | $22.5M | ||
| Q3 24 | $-46.2M | $32.8M | ||
| Q2 24 | $-20.1M | $15.6M | ||
| Q1 24 | $-45.7M | $15.8M |
| Q4 25 | 70.9% | 35.7% | ||
| Q3 25 | 71.1% | 34.1% | ||
| Q2 25 | 71.2% | 36.4% | ||
| Q1 25 | 68.8% | 35.3% | ||
| Q4 24 | 70.0% | 39.1% | ||
| Q3 24 | 68.8% | 34.1% | ||
| Q2 24 | 69.9% | 33.5% | ||
| Q1 24 | 66.3% | 32.7% |
| Q4 25 | 1.1% | 17.0% | ||
| Q3 25 | -4.4% | 13.9% | ||
| Q2 25 | -10.0% | 7.8% | ||
| Q1 25 | -20.5% | 15.5% | ||
| Q4 24 | -2.5% | 20.0% | ||
| Q3 24 | -34.1% | 15.6% | ||
| Q2 24 | -15.5% | 10.2% | ||
| Q1 24 | -28.9% | 7.3% |
| Q4 25 | 2.7% | 14.7% | ||
| Q3 25 | -2.7% | 15.3% | ||
| Q2 25 | -7.6% | 11.3% | ||
| Q1 25 | -19.3% | 12.2% | ||
| Q4 24 | -0.8% | 11.6% | ||
| Q3 24 | -31.3% | 14.5% | ||
| Q2 24 | -13.6% | 10.4% | ||
| Q1 24 | -34.6% | 10.3% |
| Q4 25 | $0.18 | — | ||
| Q3 25 | $-0.16 | — | ||
| Q2 25 | $-0.44 | — | ||
| Q1 25 | $-0.97 | — | ||
| Q4 24 | $-0.03 | — | ||
| Q3 24 | $-1.48 | — | ||
| Q2 24 | $-0.65 | — | ||
| Q1 24 | $-1.47 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $583.8M | $176.6M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $152.7M | $941.0M |
| Total Assets | $1.0B | $1.3B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $583.8M | $176.6M | ||
| Q3 25 | $565.2M | $119.8M | ||
| Q2 25 | $545.5M | $170.5M | ||
| Q1 25 | $520.6M | $176.6M | ||
| Q4 24 | $535.6M | $194.6M | ||
| Q3 24 | $522.0M | $163.2M | ||
| Q2 24 | $561.5M | $131.2M | ||
| Q1 24 | $569.1M | $159.4M |
| Q4 25 | $152.7M | $941.0M | ||
| Q3 25 | $121.9M | $918.9M | ||
| Q2 25 | $103.7M | $893.1M | ||
| Q1 25 | $86.7M | $879.4M | ||
| Q4 24 | $90.9M | $870.7M | ||
| Q3 24 | $71.8M | $870.2M | ||
| Q2 24 | $99.2M | $841.4M | ||
| Q1 24 | $90.3M | $834.4M |
| Q4 25 | $1.0B | $1.3B | ||
| Q3 25 | $995.2M | $1.2B | ||
| Q2 25 | $964.0M | $1.2B | ||
| Q1 25 | $926.1M | $1.1B | ||
| Q4 24 | $931.4M | $1.1B | ||
| Q3 24 | $909.7M | $1.1B | ||
| Q2 24 | $919.2M | $1.1B | ||
| Q1 24 | $909.8M | $1.1B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $26.2M | $73.3M |
| Free Cash FlowOCF − Capex | $14.5M | $61.0M |
| FCF MarginFCF / Revenue | 6.9% | 31.1% |
| Capex IntensityCapex / Revenue | 5.6% | 6.3% |
| Cash ConversionOCF / Net Profit | 4.70× | 2.55× |
| TTM Free Cash FlowTrailing 4 quarters | $34.5M | $96.4M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $26.2M | $73.3M | ||
| Q3 25 | $34.9M | $62.2M | ||
| Q2 25 | $27.7M | $-8.5M | ||
| Q1 25 | $-7.9M | $3.6M | ||
| Q4 24 | $19.2M | $68.8M | ||
| Q3 24 | $24.3M | $61.3M | ||
| Q2 24 | $11.8M | $-12.6M | ||
| Q1 24 | $-52.0M | $21.4M |
| Q4 25 | $14.5M | $61.0M | ||
| Q3 25 | $20.1M | $50.7M | ||
| Q2 25 | $17.3M | $-16.0M | ||
| Q1 25 | $-17.3M | $750.0K | ||
| Q4 24 | $12.4M | $64.7M | ||
| Q3 24 | $15.5M | $55.8M | ||
| Q2 24 | $3.4M | $-16.6M | ||
| Q1 24 | $-61.8M | $16.9M |
| Q4 25 | 6.9% | 31.1% | ||
| Q3 25 | 10.4% | 21.8% | ||
| Q2 25 | 9.3% | -10.3% | ||
| Q1 25 | -10.9% | 0.5% | ||
| Q4 24 | 7.5% | 33.5% | ||
| Q3 24 | 10.5% | 24.7% | ||
| Q2 24 | 2.3% | -11.0% | ||
| Q1 24 | -46.8% | 11.0% |
| Q4 25 | 5.6% | 6.3% | ||
| Q3 25 | 7.7% | 5.0% | ||
| Q2 25 | 5.6% | 4.8% | ||
| Q1 25 | 5.9% | 1.9% | ||
| Q4 24 | 4.2% | 2.1% | ||
| Q3 24 | 6.0% | 2.4% | ||
| Q2 24 | 5.7% | 2.6% | ||
| Q1 24 | 7.4% | 2.9% |
| Q4 25 | 4.70× | 2.55× | ||
| Q3 25 | — | 1.74× | ||
| Q2 25 | — | -0.49× | ||
| Q1 25 | — | 0.20× | ||
| Q4 24 | — | 3.06× | ||
| Q3 24 | — | 1.87× | ||
| Q2 24 | — | -0.81× | ||
| Q1 24 | — | 1.35× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRTC
| Commercial Payors | $111.7M | 53% |
| Centers For Medicare And Medicaid | $49.2M | 24% |
| Healthcare Institutions | $34.3M | 16% |
| Non Contracted Third Party Payors | $13.7M | 7% |
TR
| Products | $194.3M | 99% |
| Rental And Royalty | $1.9M | 1% |
